🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this Phase I/II study is to determine the safety and effecti...
Status
Recruiting
Location
Medical University of South Carolina
Start Date
2022-03-03
Trial ID
NCT05036226
Treatments Being Tested
Background: X-Linked Chronic Granulomatous Disease (X-CGD) is caused by a ...
Status
Enrolling By Invitation
Location
National Institutes of Health Clinical Center
Start Date
2025-09-10
Trial ID
NCT07113743
Study Title A post market registry of Abluminus® sirolimus eluting coronary...
Status
Unknown
Location
IRCCS Pol. San Donato
Start Date
2017-01
Trial ID
NCT03509532
Treatments Being Tested
NET originate in neuroendocrine cells throughout the body. The goal of this...
Status
Unknown
Location
Oncology Centre, King Faisal Specialist Hospital & Research Center
Start Date
2012-12
Trial ID
NCT03629847
Treatments Being Tested
A Phase 2 multi-center open-label basket trial of nab-sirolimus for adult a...
Status
Active Not Recruiting
Location
Alabama Oncology
Start Date
2022-02-15
Trial ID
NCT05103358
Treatments Being Tested
This study aims to conduct a randomized, double blind, randomised controlle...
Status
Recruiting
Location
Khoo Teck Puat Hospital
Start Date
2020-09-08
Trial ID
NCT04511234
Treatments Being Tested
The main objective of this study is to assess in-stent late lumen loss in d...
Status
Terminated
Location
Foundation for Cardiovascular Medicine
Start Date
2002-08
Trial ID
NCT00489164
Treatments Being Tested
Cisplatin and Etoposide is the standard of care in NEC originating from the...
Status
Unknown
Location
S.C. Oncologia - Policlinico
Start Date
2015-05
Trial ID
NCT02687958
Treatments Being Tested
All subjects requiring percutaneous coronary intervention (PCI) and stentin...
Status
Completed
Location
Division of Cardiology, Queen Mary Hospital, The University of Hong Kong
Start Date
2010-10
Trial ID
NCT01274234
Treatments Being Tested
Everolimus is an oral mTOR inhibitor with demonstrated preliminary efficacy...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2009-05
Trial ID
NCT00869999
Treatments Being Tested